Monitoring the safety of COVID-19 vaccines in pregnancy in the US
Pregnant persons are at increased risk of severe illness from COVID-19. The first COVID-19 vaccines in the U.S. were authorized for emergency use in December 2020 and pregnant persons were eligible and could get vaccinated despite scarce safety data in this population. To monitor the safety of COVID...
| Published in: | Human Vaccines & Immunotherapeutics |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2021-12-01
|
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2021.1984132 |